MGO One Seven’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,763
Closed -$251K 682
2021
Q3
$251K Sell
4,763
-66
-1% -$3.6K 0.03% 499
2021
Q2
$268K Buy
4,829
+355
+8% +$18.9K 0.04% 481
2021
Q1
$209K Buy
+4,474
New +$217K 0.04% 500

Other funds holding HCAT

MGO One Seven's HCAT Position: Q4 2021 in Review

MGO One Seven sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 4,763 shares — an estimated $251K sold.

MGO One Seven first reported a position in HCAT in Q1 2021 and held it in 3 quarters. The position peaked at $268K in Q2 2021. 187 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

  • MGO One Seven reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
  • MGO One Seven sold 4,763 Health Catalyst shares in Q4 2021, an estimated $251K.
  • MGO One Seven first reported a position in Health Catalyst in Q1 2021 and held it in 3 quarters.
  • MGO One Seven's Health Catalyst position peaked at $268K in Q2 2021.
  • 187 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on MGO One Seven's 13F filing for Q4 2021, filed 9 Feb 2022.